Ms. Helfer currently serves as president and CEO of Halo Healthcare, a medical device and diagnostics company that develops technologies for early risk detection of breast cancer.
Mr. Ward has more than 20 years of life sciences-dedicated investment banking, venture capital and private equity experience. He was previously a director at Lurie Investments, where he was responsible for managing investment activities.
Aperion Biologics is a privately owned, clinical-stage medical device company.
More Articles on Devices:
5 Key Results: LDR’s Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE’s Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018
